1 study on AD-IR10 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research highlights AD-IR10 as a promising novel therapeutic agent for accelerating diabetic wound healing. Its unique mechanism of action, involving the reprogramming of macrophage metabolism via the Keap1/Nrf2/…